Novo Nordisk
NVO
#112
Rank
HK$1.354 T
Marketcap
HK$307.05
Share price
2.22%
Change (1 day)
-23.08%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

ESG Reports

Thumbnail Novo Nordisk ESG Report 2024

ESG Report 2024

Language: English

View ESG Report